DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Premarin (Conjugated Estrogens) - Adverse Event Reports - Hospitalization - Breast Cancer Metastatic

 



Index of reports > Cases resulting in hospitalization (132) > Cases with Breast Cancer Metastatic (46)

Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in hospitalization where reactions include breast cancer metastatic.

 Reports 1 - 25 of 46   Next >>

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female, weighing 59.0 kg (129.8 pounds)

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Dosage: unknown
    Indication: Oestrogen Replacement Therapy
    Start date: 1994-01-01
    End date: 1996-01-01

Estrace

Provera
    Dosage: unknown
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 2002-01-01

Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 2002-01-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Estradiol

Provera

Estrace

Premarin

Medroxyprogesterone Acetate



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Indication: Hormone Replacement Therapy

Provera
    Indication: Hormone Replacement Therapy



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-10-29

Patient: female, weighing 58.6 kg (128.9 pounds)

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Other drugs received by patient: Remicade; Synthroid



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-29

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Medroxyprogesterone

Estratest

Premarin

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-26

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-24

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Premphase 14 / 14



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-24

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Indication: Menopausal Symptoms

Medroxyprogesterone Acetate

Cenestin

Estratest

Premarin

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-24

Patient: female, weighing 56.8 kg (124.9 pounds)

Adverse reactions / side effects: Breast Cancer Metastatic, Metastases TO Lymph Nodes

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2000-01-01
    End date: 2001-01-01

Premarin
    Dosage: unknown
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2000-01-01
    End date: 2001-01-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Provera

Premarin



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic, Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate

Medroxyprogesterone Acetate
    Indication: Menopause

Premarin
    Indication: Hormone Replacement Therapy



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 1999-01-01

Provera

Premarin
    Dosage: unspecified sample doses
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1990-01-01
    End date: 1999-01-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Medroxyprogesterone Acetate

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-19

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Premarin
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 1993-01-01
    End date: 2001-01-01

Prefest

Ortho-EST

Provera
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 1993-01-01
    End date: 2001-01-01

Prempro



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-16

Patient: female, weighing 94.4 kg (207.7 pounds)

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Medroxyprogesterone Acetate

Provera

Premarin



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-05

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Hormone Replacement Therapy

Provera
    Indication: Hormone Replacement Therapy



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-04

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Provera

Medroxyprogesterone Acetate

Premarin



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-04

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-02

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Indication: Hormone Replacement Therapy

Estratab
    Indication: Hormone Replacement Therapy

Provera



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-27

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro
    Indication: Hormone Replacement Therapy

Provera

Cycrin

Premarin



Adverse event in 75 year old female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-07-13

Patient: 75 year old female, weighing 65.3 kg (143.7 pounds)

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Activella
    Dosage: 1 mg/0.5 mg, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2000-11-22
    End date: 2001-12-10

Activella
    Dosage: 1 mg/0.5 mg, oral
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2000-11-22
    End date: 2001-12-10

Premarin
    Dosage: 0.625 mg, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1989-09-25
    End date: 2000-11-01

Provera
    Dosage: 10 mg, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1989-09-25
    End date: 2000-11-01

Femhrt
    Dosage: oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2001-12-27
    End date: 2002-11-07

Hormone Replacements Drugs (Nos)
    Indication: Menopausal Symptoms
    Start date: 1991-10-31

Cycrin
    Indication: Menopausal Symptoms
    Start date: 1998-12-17
    End date: 1999-07-14

Medroxyprogesterone Acetate
    Indication: Menopausal Symptoms
    Start date: 1999-09-27
    End date: 2000-08-07

Other drugs received by patient: Lipitor; Fosamax; Synthroid; Enalapril (Enalapril); Vioxx; Elavil



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-06

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Dosage: unspecified
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1980-01-01
    End date: 1990-01-01

Ogen

Provera



Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-03

Patient: 63 year old female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Prempro

Provera

Medroxyprogesterone Acetate

Premarin



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-07-03

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Norethindrone Acetate

Estradiol

Provera

Other drugs received by patient: Zomepirac



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009